HPV and head and neck cancers: State-of-the-science

Oral Oncology

Volumn 50, Issue 5, 2014, Pages 353-355

  Fakhry, Carole ^a   Psyrri, Amanda ^b   Chaturvedhi, Anil ^c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL CONSUMPTION; CANCER INCIDENCE; CANCER PREVENTION; EDITORIAL; HEAD AND NECK CANCER; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFECTION PREVENTION; NONHUMAN; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION; SEXUAL BEHAVIOR; SMOKING; VIRUS ETIOLOGY; VIRUS GENOME; WART VIRUS; HEAD AND NECK TUMOR; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; VIROLOGY;

HEAD AND NECK NEOPLASMS; HUMANS; PAPILLOMAVIRIDAE;

EID: 84898847255     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2014.03.010     Document Type: Article

References (39)

1. G. D'Souza, A.R. Kreimer, and R. Viscidi et al. Case-control study of human papillomavirus and oropharyngeal cancer N Engl J Med 356 2007 1944 1956
2. M.L. Gillison, G. D'Souza, and W. Westra et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers J Natl Cancer Inst 100 2008 407 420
3. M.L. Gillison Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity Semin Oncol 31 2004 744 754
4. A.K. Chaturvedi, E.A. Engels, W.F. Anderson, and M.L. Gillison Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States J Clin Oncol 26 2008 612 619
5. A.K. Chaturvedi, W.F. Anderson, and J. Lortet-Tieulent et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers J Clin Oncol 31 2013 4550 4559
6. A.K. Chaturvedi, E.A. Engels, and R.M. Pfeiffer et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States J Clin Oncol 29 2011 4294 4301
7. L. Hammarstedt, D. Lindquist, and H. Dahlstrand et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer Int J Cancer 119 2006 2620 2623
8. K.B. Pytynia, K.R. Dahlstrom, and E.M. Sturgis Epidemiology of HPV-associated oropharyngeal cancer Oral Oncol 2014
9. M.L. Gillison, T. Broutian, and R.K. Pickard et al. Prevalence of oral HPV infection in the United States, 2009-2010 JAMA 307 2012 693 703
10. C.H. Chung, A. Bagheri, and G. D'Souza Epidemiology of oral human papillomavirus infection Oral Oncol 2013
11. J.D. Combes, and S. Franceschi Role of human papillomavirus in non-oropharyngeal head and neck cancers Oral Oncol 2013
12. M.W. Lingen, W. Xiao, and A. Schmitt et al. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas Oral Oncol 49 2013 1 8
13. M. Schiffman, and N. Wentzensen Human papillomavirus infection and the multistage carcinogenesis of cervical cancer Cancer Epidemiol Biomarkers Prev 22 2013 553 560
14. A.R. Kreimer Prospects for prevention of HPV-driven oropharynx cancer Oral Oncol 2013
15. R. Herrero, W. Quint, and A. Hildesheim et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica PLoS One 8 2013 e68329
16. C. Fakhry, B.T. Rosenthal, D.P. Clark, and M.L. Gillison Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations Cancer Prev Res (Phila) 4 2011 1378 1384
17. E. Benson, R. Li, D. Eisele, and C. Fakhry The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas Oral Oncol 2013
18. H. Mirghani, F. Amen, and F. Moreau et al. Human papilloma virus testing in oropharyngeal squamous cell carcinoma: what the clinician should know Oral Oncol 50 2014 1 9
19. C. Fakhry, and M.L. Gillison Clinical implications of human papillomavirus in head and neck cancers J Clin Oncol 24 2006 2606 2611
20. C. Fakhry, W.H. Westra, and S. Li et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 100 2008 261 269
21. K.K. Ang, J. Harris, and R. Wheeler et al. Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 2010 24 35
22. B. O'Sullivan, S.H. Huang, and B. Perez-Ordonez et al. Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation Radiother Oncol 103 2012 49 56
23. J.B. Vermorken, A. Psyrri, and R. Mesia et al. Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial Ann Oncol 2014
24. R. Mehra, S. Li, and D. Yang et al. Analysis of HPV and ERCC1 in recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) [abstract]Mehra R, Li S, Yang D et al. Am Soc Clin Oncol 2013
25. C. Fakhry, Q. Zhang, and P.F. Nguyen-Tan et al. Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma [abstract]Fakhry C, Zhang Q, Nguyen-Tan PF et al. 2014 Multidiscipl Head Neck Cancer Symp 2014
26. R.J. Kimple, and P.M. Harari Is radiation dose reduction the right answer for HPV-positive head and neck cancer Oral Oncol 2013
27. T. Rampias, C. Sasaki, and A. Psyrri Molecular mechanisms of HPV induced carcinogenesis in head and neck Oral Oncol 2013
28. S. Kuhnle, B. Mothes, K. Matentzoglu, and M. Scheffner Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein Arc Proc Natl Acad Sci USA 110 2013 8888 8893
29. S.N. Boyer, D.E. Wazer, and V. Band E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway Cancer Res 56 1996 4620 4624
30. L. Cao, B. Faha, M. Dembski, L.H. Tsai, E. Harlow, and N. Dyson Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F Nature 355 1992 176 179
31. N. Dyson, P.M. Howley, K. Munger, and E. Harlow The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product Science 243 1989 934 937
32. P.M. Weinberger, Z. Yu, and B.G. Haffty et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis J Clin Oncol 24 2006 736 747
33. N.F. Schlecht, R.D. Burk, and L. Adrien et al. Gene expression profiles in HPV-infected head and neck cancer J Pathol 213 2007 283 293
34. T. Rampias, E. Pectasides, and M. Prasad et al. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype Ann Oncol 24 2013 2124 2131
35. N. Stransky, A.M. Egloff, and A.D. Tward et al. The mutational landscape of head and neck squamous cell carcinoma Science 333 2011 1157 1160
36. N. Agrawal, M.J. Frederick, and C.R. Pickering et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1 Science 333 2011 1154 1157
37. T. Rampias, C. Sasaki, P. Weinberger, and A. Psyrri E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells J Natl Cancer Inst 101 2009 412 423
38. N. Gildener-Leapman, J. Lee, and R.L. Ferris Tailored immunotherapy for HPV positive head and neck squamous cell cancer Oral Oncol 2013
39. C. Fakhry, and G. D'Souza Discussing the diagnosis of HPV-OSCC: common questions and answers Oral Oncol 49 2013 863 871